Reply: Irinotecan in patients with relapsed or cisplatin-refractory germ cell cancer: a phase II study of the German Testicular Cancer Study Group

著者: Kollmannsberger, C, Bokemeyer, C
出版事項 2003

Efficacy of cytotoxic agents used in the treatment of testicular germ cell tumours under normoxic and hypoxic conditions in vitro

著者: Koch, S, Mayer, F, Honecker, F, Schittenhelm, M, Bokemeyer, C
出版事項 2003

Endocrinological late effects after chemotherapy for testicular cancer.

著者: Berger, C. C., Bokemeyer, C., Schuppert, F., Schmoll, H. J.
出版事項 1996

Tumour shrinkage measured with first treatment evaluation under VEGF-targeted therapy as prognostic marker in metastatic renal cell carcinoma (mRCC)

著者: Seidel, C, Busch, J, Weikert, S, Steffens, S, Bokemeyer, C, Grünwald, V
出版事項 2013

The anti-tumour activity of ifosfamide on heterotransplanted testicular cancer cell lines remains unaltered by the uroprotector mesna.

著者: Bokemeyer, C., Schmoll, H. J., Ludwig, E., Harstrick, A., Dunn, T., Casper, J.
出版事項 1994

Esophageal squamous cell carcinoma presenting with extensive skin lesions: a case report

著者: Iwanski, GB, Block, A, Keller, G, Muench, J, Claus, S, Fiedler, W, Bokemeyer, C
出版事項 2008

Activity and side effects of imatinib in patients with gastrointestinal stromal tumors: data from a german multicenter trial

著者: Schlemmer, M, Bauer, S, Schütte, R, Hartmann, JT, Bokemeyer, C, Hosius, C, Reichardt, P
出版事項 2011

Long-term effects on sexual function and fertility after treatment of testicular cancer

著者: Hartmann, J T, Albrecht, C, Schmoll, H-J, Kuczyk, M A, Kollmannsberger, C, Bokemeyer, C
出版事項 1999

A randomized trial of amifostine in patients with high-dose VIC chemotherapy plus autologous blood stem cell transplanation

著者: Hartmann, J T, Vangerow, A von, Fels, L M, Knop, S, Stolte, H, Kanz, L, Bokemeyer, C
出版事項 2001

p53 immunohistochemistry as an independent prognostic factor for superficial transitional cell carcinoma of the bladder.

著者: Serth, J., Kuczyk, M. A., Bokemeyer, C., Hervatin, C., Nafe, R., Tan, H. K., Jonas, U.
出版事項 1995

Treatment-induced anaemia and its potential clinical impact in patients receiving sequential high dose chemotherapy for metastatic testicular cancer

著者: Bokemeyer, C, Oechsle, K, Hartmann, J T, Schöffski, P, Schleucher, N, Metzner, B, Schleicher, J, Kanz, L
出版事項 2002

Silibinin protects against cisplatin-induced nephrotoxicity without compromising cisplatin or ifosfamide anti-tumour activity.

著者: Bokemeyer, C., Fels, L. M., Dunn, T., Voigt, W., Gaedeke, J., Schmoll, H. J., Stolte, H., Lentzen, H.
出版事項 1996

Analysis of risk factors for cisplatin-induced ototoxicity in patients with testicular cancer.

著者: Bokemeyer, C., Berger, C. C., Hartmann, J. T., Kollmannsberger, C., Schmoll, H. J., Kuczyk, M. A., Kanz, L.
出版事項 1998

Activating BRAF gene mutations are uncommon in hormone refractory prostate cancer in Caucasian patients

著者: KÖLLERMANN, J., ALBRECHT, H., SCHLOMM, T., HULAND, H., GRAEFEN, M., BOKEMEYER, C., SIMON, R., SAUTER, G., WILCZAK, W.
出版事項 2010

Early prediction of treatment response to high-dose salvage chemotherapy in patients with relapsed germ cell cancer using [(18)F]FDG PET

著者: Bokemeyer, C, Kollmannsberger, C, Oechsle, K, Dohmen, B M, Pfannenberg, A, Claussen, C D, Bares, R, Kanz, L
出版事項 2002

Predictive value of decreased p27(Kip1) protein expression for the recurrence-free and long-term survival of prostate cancer patients

著者: Kuczyk, M, Machtens, S, Hradil, K, Schubach, J, Christian, W, Knüchel, R, Hartmann, J, Bokemeyer, C, Jonas, U, Serth, J
出版事項 1999

Improved nutrition in adolescents and young adults after childhood cancer - INAYA study

著者: Quidde, J., von Grundherr, J., Koch, B., Bokemeyer, C., Escherich, G., Valentini, L., Buchholz, D., Schilling, G., Stein, A.
出版年 BMC Cancer (2016)

A phase II study of paclitaxel, weekly, 24-hour continuous infusion 5-fluorouracil, folinic acid and cisplatin in patients with advanced gastric cancer

著者: Kollmannsberger, C, Quietzsch, D, Haag, C, Lingenfelser, T, Schroeder, M, Hartmann, J T, Baronius, W, Hempel, V, Clemens, M, Kanz, L, Bokemeyer, C
出版事項 2000

First-line sequential high-dose VIP chemotherapy with autologous transplantation for patients with primary mediastinal nonseminomatous germ cell tumours: a prospective trial

著者: Bokemeyer, C, Schleucher, N, Metzner, B, Thomas, M, Rick, O, Schmoll, H-J, Kollmannsberger, C, Boehlke, I, Kanz, L, Hartmann, J T
出版事項 2003

Capecitabine in combination with mitomycin C in patients with gastrointestinal cancer: results of an extended multicentre phase-I trial

著者: Hofheinz, R-D, Hartmann, J T, Willer, A, Oechsle, K, Hartung, G, Gnad, U, Saussele, S, Kreil, S, Bokemeyer, C, Hehlmann, R, Hochhaus, A
出版事項 2004